Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Intra-Cellular Therapies Inc. (ITCI)

13.71   -0.38 (-2.7%) 06-20 09:46
Open: 14.31 Pre. Close: 14.09
High: 14.34 Low: 13.68
Volume: 80,470 Market Cap: 756M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.303 - 14.373 14.373 - 14.432
Low: 13.537 - 13.616 13.616 - 13.684
Close: 13.971 - 14.094 14.094 - 14.201

Technical analysis

as of: 2019-06-19 4:32:03 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 16.83     One year: 19.66
Support: Support1: 11.89    Support2: 10.34
Resistance: Resistance1: 14.41    Resistance2: 16.83
Pivot: 12.43
Moving Average: MA(5): 13.50     MA(20): 12.61
MA(100): 12.85     MA(250): 15.83
MACD: MACD(12,26): 0.16     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 91.62     %D(3): 84.06
RSI: RSI(14): 61.29
52-week: High: 23.62  Low: 10.21  Change(%): -28.2
Average Vol(K): 3-Month: 36495  10-Days: 60372

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ITCI has closed below upper band by 10.5%. Bollinger Bands are 92.6% wider than normal. The large width of the bands suggest high volatility as compared to ITCI's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Mon, 17 Jun 2019 16:29:32 Z
Monday 6/17 Insider Buying Report: ITCI, CNR

Wed, 08 May 2019 21:55:18 Z
Uber: Pre-IPO Observations On Performance

Wed, 08 May 2019 19:26:49 Z
Intra-Cellular Therapies, Inc. (ITCI) Q1 2019 Earnings Call Transcript

Thu, 21 Mar 2019 21:08:23 Z
Notable Thursday Option Activity: CLW, GPRE, ITCI

Wed, 27 Feb 2019 18:11:25 Z
Intra-Cellular Therapies Inc (ITCI) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 55.13
Shares Float (M) 52.65
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.840
EPS Est. Current Year -2.340
EPS Est. Next Year -2.810
EPS Est. Next Quarter -0.690
Forward EPS -3.041
Book Value (p.s.) 2.150
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -41.3
Return on Equity (ttm) -45.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -126.81
Levered Free Cash Flow (M) -73.78

Stock Valuations

P/E -4.96
P/E Growth Ratio 0.01
P/BV 6.55
P/CF -6.13

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.